U.S. Asthma/COPD Market

U.S. Asthma/COPD Market

 

RELEASE DATE
23-Oct-2007
REGION
North America
Research Code: N169-01-00-00-00
SKU: HC02033-NA-MR_07348
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02033-NA-MR_07348

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

Executive Summary

  • Introduction

Overview

  • Scope and Segmentation
  • Research Methodology

Disease Overview

  • Asthma
  • COPD
  • Treatment Options

Market Overview

  • Market Engineering Measurements
  • Industry Challenges and Strategic Recommendations
  • Market Drivers
  • Market Restraints

Competitive Analysis

Patient Forecasts

Revenue Forecasts

  • Competitive Structure

Introduction

Short-Acting Beta-2 Agonists Market

Long-Acting Beta-2 Agonists Market

Anticholinergics Market

Combination Bronchodilators

  • Introduction
  • Market Engineering Measurements
  • Revenue Forecasts
  • Market Share Analysis

Introduction

Inhaled Corticosteroids Market

Mediator-Release Inhibitor Market

Anti-Leukotriene Market

Monoclonal Antibody Market

Other Emerging Anti-Inflammatories

Decision Support Databases

Related Research
This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number N169-01-00-00-00
Is Prebook No